Literature DB >> 28707070

Functional Role of Matrix gla Protein in Glioma Cell Migration.

Mu-Hui Fu1,2, Chih-Yen Wang3, Yun-Ti Hsieh3, Kuan-Min Fang3, Shun-Fen Tzeng4,5.   

Abstract

Glioblastoma multiforme (GBM) is the most common and aggressive brain tumor subtype. Despite that metastasis of GBM beyond the central nervous system (CNS) is rare, its malignancy is attributed to the highly infiltration trait, leading to the difficulty of complete surgical excision. Matrix gla protein (MGP) is a vitamin K-dependent small secretory protein, and functions as a calcification inhibitor. The involvement of MGP function in glioma cell dynamics remains to be clarified. The study showed that a low proliferative rat C6 glioma cell line named as C6-2 exhibited faster migratory and invasive capability compared to that observed in a high tumorigenic rat C6 glioma cell line (called as C6-1). Interestingly, C6-2 cells expressed higher levels of MGP molecules than C6-1 cells did. Lentivirus-mediated short hairpin RNA (shRNA) against MGP gene expression (MGP-KD) in C6-2 cells or lentivirus-mediated overexpression of MGP transcripts in C6-1 cells resulted in the morphological alteration of the two cell lines. Moreover, MGP-KD caused a decline in cell migration and invasion ability of C6-2 cells. In contrast, increased expression of MGP in C6-1 cells promoted their cell migration and invasion. The observations were further verified by the results from the implantation of C6-1 and C6-2 cells into ex vivo brain slice and in vivo rat brain. Thus, our results demonstrate that the manipulation of MGP expression in C6 glioma cells can mediate glioma cell migratory activity. Moreover, our findings indicate the possibility that high proliferative glioma cells expressing a high level of MGP may exist and contribute to tumor infiltration and recurrence.

Entities:  

Keywords:  Cell invasion; Cell migration; Ex vivo model; Glioblastoma multiforme; Glioma; Matrix gla protein

Mesh:

Substances:

Year:  2017        PMID: 28707070     DOI: 10.1007/s12035-017-0677-1

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  39 in total

1.  Dichotomy of astrocytoma migration and proliferation.

Authors:  A Giese; M A Loo; N Tran; D Haskett; S W Coons; M E Berens
Journal:  Int J Cancer       Date:  1996-07-17       Impact factor: 7.396

2.  Matrix-Gla protein promotes osteosarcoma lung metastasis and associates with poor prognosis.

Authors:  Carolina Zandueta; Cristina Ormazábal; Naiara Perurena; Susana Martínez-Canarias; Marta Zalacaín; Mikel San Julián; Agamemnon E Grigoriadis; Karmele Valencia; Francisco J Campos-Laborie; Javier De Las Rivas; Silvestre Vicent; Ana Patiño-García; Fernando Lecanda
Journal:  J Pathol       Date:  2016-06-29       Impact factor: 7.996

Review 3.  Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion.

Authors:  Bert Grobben; Peter Paul De Deyn; Herman Slegers
Journal:  Cell Tissue Res       Date:  2002-11-06       Impact factor: 5.249

Review 4.  Cost of migration: invasion of malignant gliomas and implications for treatment.

Authors:  A Giese; R Bjerkvig; M E Berens; M Westphal
Journal:  J Clin Oncol       Date:  2003-04-15       Impact factor: 44.544

Review 5.  Epidemiology of brain tumors.

Authors:  Hiroko Ohgaki
Journal:  Methods Mol Biol       Date:  2009

6.  IL-6 is required for glioma development in a mouse model.

Authors:  Jakob Weissenberger; Sébastien Loeffler; Andreas Kappeler; Manfred Kopf; Anton Lukes; Tatiana A Afanasieva; Adriano Aguzzi; Joachim Weis
Journal:  Oncogene       Date:  2004-04-22       Impact factor: 9.867

Review 7.  Glioblastoma: from molecular pathology to targeted treatment.

Authors:  Timothy F Cloughesy; Webster K Cavenee; Paul S Mischel
Journal:  Annu Rev Pathol       Date:  2013-08-05       Impact factor: 23.472

8.  Matrix Gla protein repression by miR-155 promotes oncogenic signals in breast cancer MCF-7 cells.

Authors:  Daniel M Tiago; Natércia Conceição; Helena Caiado; Vincent Laizé; Maria Leonor Cancela
Journal:  FEBS Lett       Date:  2016-04-06       Impact factor: 4.124

9.  Detecting glioma invasion of the corpus callosum using diffusion tensor imaging.

Authors:  S J Price; A Peña; N G Burnet; J D Pickard; J H Gillard
Journal:  Br J Neurosurg       Date:  2004-08       Impact factor: 1.596

Review 10.  Diffuse glioma growth: a guerilla war.

Authors:  An Claes; Albert J Idema; Pieter Wesseling
Journal:  Acta Neuropathol       Date:  2007-09-06       Impact factor: 17.088

View more
  4 in total

1.  SLC39A7 promotes malignant behaviors in glioma via the TNF-α-mediated NF-κB signaling pathway.

Authors:  Lian Chen; Jinpeng Zhou; Long Li; Junshuang Zhao; Hao Li; Wei Zheng; Jinkun Xu; Zhitao Jing
Journal:  J Cancer       Date:  2021-06-01       Impact factor: 4.207

2.  The Role of Matrix Gla Protein (MGP) Expression in Paclitaxel and Topotecan Resistant Ovarian Cancer Cell Lines.

Authors:  Karolina Sterzyńska; Andrzej Klejewski; Karolina Wojtowicz; Monika Świerczewska; Małgorzata Andrzejewska; Damian Rusek; Maciej Sobkowski; Witold Kędzia; Jacek Brązert; Michał Nowicki; Radosław Januchowski
Journal:  Int J Mol Sci       Date:  2018-09-25       Impact factor: 5.923

3.  Prosaposin promotes the proliferation and tumorigenesis of glioma through toll-like receptor 4 (TLR4)-mediated NF-κB signaling pathway.

Authors:  Yang Jiang; Jinpeng Zhou; Peng Luo; Huiling Gao; Yanju Ma; Yin-Sheng Chen; Long Li; Dan Zou; Ye Zhang; Zhitao Jing
Journal:  EBioMedicine       Date:  2018-10-29       Impact factor: 8.143

4.  RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner.

Authors:  Kai Zhao; Xiaoteng Cui; Qixue Wang; Chuan Fang; Yanli Tan; Yunfei Wang; Kaikai Yi; Chao Yang; Hua You; Rui Shang; Jiachong Wang; Chunsheng Kang
Journal:  Cell Death Dis       Date:  2019-11-21       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.